Anelisa Jaca1, Alison Beriliy Wiyeh1, Evanson Zondani Sambala1, Charles Shey Wiysonge1,2,3. 1. Cochrane South Africa, South African Medical Research Council, Francie van Zijl Drive, Parow Valley, 7501, South Africa. 2. Centre for Evidence-based Health Care, Division of Epidemiology and Biostatistics, Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa. 3. Division of Epidemiology and Biostatistics, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
Abstract
INTRODUCTION: Neisseria meningitides is the leading cause of meningitis in the African Meningitis Belt. The objective of this study was to conduct a trend analysis of the burden of meningococcal meningitis in the African Meningitis Belt countries from 2009 to 2014. METHODS: secondary data on incidence and death cases were collected from the World Health Organization (WHO) and analyzed to determine the trends of meningitis in the African Meningitis Belt countries using Microsoft excel and Stata 14. RESULTS: these data show unstable meningococcal meningitis outbreaks in the Meningitis Belt before and after the introduction of meningococcal A vaccine (MenAfriVac). The vaccine was introduced at different times in the different countries. E.g. it was introduced in 2010 across Burkina Faso, Mali and Niger while it was introduced from 2011 to 2016 in other countries through mass campaigns. Ever since the vaccine was introduced, there has been a decrease in the number of cases in the countries hence a reduction in the burden of the disease. CONCLUSION: after the introduction of the MenAfriVac, there has been a decline in the meningitis cases in Benin, Burkina Faso, Chad, Ghana, Niger and Nigeria while Sudan shows a decrease only in 2014. Copyright: Anelisa Jaca et al.
INTRODUCTION: Neisseria meningitides is the leading cause of meningitis in the African Meningitis Belt. The objective of this study was to conduct a trend analysis of the burden of meningococcal meningitis in the African Meningitis Belt countries from 2009 to 2014. METHODS: secondary data on incidence and death cases were collected from the World Health Organization (WHO) and analyzed to determine the trends of meningitis in the African Meningitis Belt countries using Microsoft excel and Stata 14. RESULTS: these data show unstable meningococcal meningitis outbreaks in the Meningitis Belt before and after the introduction of meningococcal A vaccine (MenAfriVac). The vaccine was introduced at different times in the different countries. E.g. it was introduced in 2010 across Burkina Faso, Mali and Niger while it was introduced from 2011 to 2016 in other countries through mass campaigns. Ever since the vaccine was introduced, there has been a decrease in the number of cases in the countries hence a reduction in the burden of the disease. CONCLUSION: after the introduction of the MenAfriVac, there has been a decline in the meningitis cases in Benin, Burkina Faso, Chad, Ghana, Niger and Nigeria while Sudan shows a decrease only in 2014. Copyright: Anelisa Jaca et al.
Entities:
Keywords:
Emerging strains; MenAfriVac; meningitis; meningitis belt; serogroup A
Authors: Danny Altmann; Abraham Aseffa; Margaret Bash; Nicole Basta; Ray Borrow; Claire Broome; Dominique Caugant; Tom Clark; Jean-Marc Collard; Mamoudou Djingarey; David Goldblatt; Brian Greenwood; Ulla Griffiths; Rana Hajjeh; Musa Hassan-King; Stephane Hugonnet; Ann Marie Kimball; Marc LaForce; Calman MacLennan; Martin C J Maiden; Olivier Manigart; Leonard Mayer; Nancy Messonnier; Jennifer Moisi; Katie Moore; Daugla Doumagoum Moto; Judith Mueller; Maria Nascimento; Stephen Obaro; Rasmata Ouedraogo; Anne-Laure Page; Willima Perea; Gerd Pluschke; Mari-Pierre Preziosi; Samba Sow; David Stephens; James Stuart; Madeleiene Thomson; Sylvestre Tiendrebeogo; Jean-Francois Trape; Guy Vernet Journal: Vaccine Date: 2012-12-27 Impact factor: 3.641
Authors: Scott A Halperin; Julie A Bettinger; Brian Greenwood; Lee H Harrison; Jane Jelfs; Shamez N Ladhani; Peter McIntyre; Mary E Ramsay; Marco A P Sáfadi Journal: Vaccine Date: 2011-12-15 Impact factor: 3.641
Authors: Robert Domo Nuoh; Kofi Mensah Nyarko; Priscilla Nortey; Samuel Oko Sackey; Noora Charles Lwanga; Donne Kofi Ameme; Culbert Nuolabong; Marijanatu Abdulai; Fredrick Wurapa; Edwin Afari Journal: Pan Afr Med J Date: 2016-10-01
Authors: Aleksandra Polkowska; Maija Toropainen; Jukka Ollgren; Outi Lyytikäinen; J Pekka Nuorti Journal: BMJ Open Date: 2017-06-06 Impact factor: 2.692
Authors: Usman N Ikumapayi; Philip C Hill; Ilias Hossain; Yekini Olatunji; Malick Ndiaye; Henry Badji; Ahmed Manjang; Rasheed Salaudeen; Lamin Ceesay; Richard A Adegbola; Brian M Greenwood; Grant A Mackenzie Journal: PLoS One Date: 2022-08-10 Impact factor: 3.752